Karen Jean Ferrante

Director, PROGENICS PHARMACEUTICALS INC.

Companies

Cogent Biosciences, Inc.Board member Mar 28, 2018 to now¹
MACROGENICS INCBoard member Jan 25, 2017 to now²
Eledon Pharmaceuticals, Inc.Head Res. & Dev. & Chief Med. Sep 16, 2014 to Dec 17, 2015³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

MACROGENICS INC MGNX14,750 shares⁴$49.2K at $3.33May 18, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

May 18, 2026Exercised options 3,750 shares of MACROGENICS INC⁴
May 20, 2025Exercised options 6,500 shares of MACROGENICS INC⁵
May 20, 2024Exercised options 4,500 shares of MACROGENICS INC⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCogent Biosciences, Inc., Board member
2
SEC EDGARMACROGENICS INC, Board member
3
SEC EDGAREledon Pharmaceuticals, Inc., Head Res. & Dev. & Chief Med.
4
SEC EDGARMACROGENICS INC shares after the filing of May 18, 2026
5
SEC EDGARForm 4 filed May 22, 2025
6
SEC EDGARForm 4 filed May 22, 2024